Analysis of incidence, risk factors and clinical outcome of thromboembolic and bleeding events in 431 allogeneic hematopoietic stem cell transplantation recipients

Haematologica

Volumn 98, Issue 3, 2013, Pages 437-443

  Labrador, Jorge ^a   Lopez Anglada, Lucia ^a   Perez Lopez, Estefania ^a   Lozano, Francisco S ^a   Lopez Corral, Lucia ^a   Sanchez Guijo, Fermin M ^a   Vazquez, Lourdes ^a   Rivera, Jose Angel Perez ^a   Martin Herrero, Francisco ^a   Sanchez Barba, Mercedes ^b   Guerrero, Carmen ^b   del Cañizo, Maria Consuelo ^a   Caballero, Maria Dolores ^a   San Miguel, Jesus Fernando ^a   Alberca, Ignacio ^a   Gonzalez Porras, Jose Ramon ^a  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^b UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; ANTITHROMBOCYTIC AGENT; HEMOGLOBIN; LACTATE DEHYDROGENASE; LOW MOLECULAR WEIGHT HEPARIN;

ABLATION THERAPY; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTICOAGULATION; ARTICLE; BLEEDING; BRAIN ISCHEMIA; CELL TRANSPLANTATION; CENTRAL VENOUS CATHETER; CORONARY ARTERY DISEASE; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; MORTALITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; RETROSPECTIVE STUDY; RISK FACTOR; THROMBOEMBOLISM; UMBILICAL CORD BLOOD; VEIN THROMBOSIS; ALLOTRANSPLANTATION; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMORRHAGE; MIDDLE AGED; PROGNOSIS; SURVIVAL; YOUNG ADULT;

ADULT; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMORRHAGE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS; SURVIVAL ANALYSIS; THROMBOEMBOLISM; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 84874546490     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2012.069559     Document Type: Article

References (21)

1. Tsakiris DA, Tichelli A. Thrombotic complications after haematopoietic stem cell trans-plantation: Early and late effects. Best Pract Res Clin Haematol. 2009;22(1):137-45.
2. Pihusch R, Salat C, Schmidt E, Göhring P, Pihusch M, Hiller E, et al. Hemostatic complications in bone marrow transplantation: A retrospective analysis of 447 patients. Transplantation. 2002;74(9):1303-9.
3. Tichelli A, Bucher C, Rovó A, Stussi G, Stern M, Paulussen M, et al. Premature cardiovascular disease after allogeneic stem cell transplantation. Blood. 2007; 110(9):3463-71.
4. Tichelli A, Passweg J, Wójcik D, Rovó A, Harousseau JL, Masszi T, et al. Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation. Haematologica. 2008;93(8):1203-10.
5. Gonsalves A, Carrier M, Wells PS, McDiarmid SA, Huebsch LB, Allan DS. Incidence of symptomatic venous thromboembolism following hematopoietic stem cell transplantation. J Thromb Haemost. 2008;6(9):1468-73.
6. Gerber DE, Segal JB, Levy MY, Kane J, Jones RJ, Streiff MB. The incidence of and risk factors for venous thromboembolism (VTE) and bleeding among 1514 patients undergoing hematopoietic stem cell transplantation: implications for VTE prevention. Blood. 2008;112(3):504-10.
7. Nevo S, Vogelsang GB. Acute bleeding complications in patients after bone marrow transplantation. Curr Opin Hematol. 2001;8(5):319-25.
8. Bacigalupo A. Haemopoietic stem cell transplants: the impact of haemorrhagic complications. Blood Rev. 2003;17(1 Suppl):S6-10.
9. Pihusch M. Bleeding complications after hematopoietic stem cell transplantation. Semin Hematol. 2004;41(1 Suppl):93-100.
10. Graf L, Stern M. Acute phase after haematopoietic stem cell transplantation. Bleeding and thrombotic complications. Hamostaseologie. 2012;32(1):1-7.
11. Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE, et al. Chronic graft-versus-host syndrome in man: a long-term clinicopathologic study of 20 Seattle patients. Am J Med. 1980; 69(2):204-17.
12. Jones RJ, Lee KS, Beschorner WE, Vogel VG, Grochow LB, Braine HG, et al. Venoocclusive disease of the liver following bone marrow transplantation. Transplantation. 1987;44(6): 778-83.
13. Ruutu T, Barosi G, Benjamin RJ, Clark RE, George JN, Gratwohl A, et al. Diagnostic cri-teria for hematopoietic stem cell transplantassociated microangiopathy: results of a consensus process by an International Working Group. European Group for Blood and Marrow Transplantation; European LeukemiaNet. Haematologica. 2007;92(1): 95-100.
14. Falanga A, Marchetti M. Venous thromboembolism in the hematologic malignancies. J Clin Oncol. 2009;27(29):4848-57.
15. Stoffel N, Rysler C, Buser A, Gratwohl A, Tsakiris DA, Stern M. Leukocyte count and risk of thrombosis in patients undergoing haematopoietic stem cell transplantation or intensive chemotherapy. Thromb Haemost. 2010;103(6):1228-32.
16. Passweg JR, Baldomero H, Gratwohl A, Bregni M, Cesaro S, Dreger P, et al. The EBMT activity survey: 1990-2010. Bone Marrow Transplant. 2012;47(7):906-23.
17. Ku GH, White RH, Chew HK, Harvey DJ, Zhou H, Wun T. Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and effect on survival. Blood. 2009;113(17):3911-7.
18. Zangari M, Tricot G, Polavaram L, Zhan F, Finlayson A, Knight R, et al. Survival effect of venous thromboembolism in patients with multiple myeloma treated with lenalidomide and high-dose dexamethasone. J Clin Oncol. 2010;28(1):132-5.
19. Sørensen HT, Mellemkjaer L, Olsen JH, Baron JA. Prognosis of cancers associated with venous thromboembolism. N Engl J Med. 2000;343:1846-50.
20. Ruf W, Mueller BM. Thrombin generation and the pathogenesis of cancer. Semin Thromb Hemost. 2006;32(1 Suppl):61-8.
21. Dumler JS, Bechorner WE, Farmer ER, Di Gennaro KA, Saral R, Santos GW. Endothelial-cell injury in cutaneous acute graft-versus-host disease. Am J Pathol. 1989;135(6):1097-103